Universal group B streptococci screening not cost-effective
(HealthDay)—For women with a singleton pregnancy planning a repeat cesarean delivery, universal group B streptococci (GBS) screening is not cost-effective, according to a study published in the January issue of Obstetrics ...
Dec 13, 2016
0
0